Down-regulation of Homer1b/c protects against chemically induced seizures through inhibition of mTOR signaling

Cell Physiol Biochem. 2015;35(4):1633-42. doi: 10.1159/000373977. Epub 2015 Mar 18.

Abstract

Background: Homer is a family of post synaptic density proteins functionally and physically attached to target proteins at proline-rich sequences. Reducing Homer1b/c expression has been shown in previous studies to be protective against excitotoxic insults, implicating Homer1b/c in the physiological regulation of aberrant neuronal excitability.

Methods: To test the efficacy of a Homer1b/c reducing therapy for disorders with a detrimental hyperexcitability profile in mice, we used small interfere RNA (siRNA) to decrease endogenous Homer1b/c expression in mouse hippocampus. The baseline motor and cognitive behavior was measured by sensorimotor tests, Morris water maze and elevated plus maze tasks. The anti-epileptic effects of Homer1b/c knockdown were determined in two chemically induced seizure models induced by Picrotoxin (PTX) or pentylenetetrazole (PTZ) administration.

Results: The results of sensorimotor tests, Morris water maze and elevated plus maze tasks showed that Homer1b/c reduction had no effect on baseline motor or cognitive behavior. In two chemically induced seizure models, mice with reduced Homerb/c protein had less severe seizures than control mice. Total Homer1b/c protein levels and seizure severity were highly correlated, such that those mice with the most severe seizures also had the highest levels of Homer1b/c. In addition, the phosphorylation of mammalian target of rapamycin (mTOR) and its target protein S6 was significantly inhibited in Homer1b/c down-regulated mice. Homer1b/c knockdown-induced inhibition of mTOR pathway was partially ablated by the metabotropic glutamate receptor 5 (mGluR5) agonist CHPG.

Conclusion: Our results demonstrate that endogenous Homer1b/c is integral for regulating neuronal hyperexcitability in adult animals and suggest that reduction of Homer1b/c could protect against chemically induced seizures through inhibition mTOR pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behavior, Animal
  • Carrier Proteins / antagonists & inhibitors
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism*
  • Disease Models, Animal
  • Down-Regulation / drug effects
  • Glycine / analogs & derivatives
  • Glycine / pharmacology
  • Hippocampus / metabolism
  • Homer Scaffolding Proteins
  • Maze Learning
  • Mice
  • PC12 Cells
  • Pentylenetetrazole / toxicity
  • Phenylacetates / pharmacology
  • Phosphorylation
  • Picrotoxin / toxicity
  • RNA Interference
  • Rats
  • Receptor, Metabotropic Glutamate 5 / agonists
  • Receptor, Metabotropic Glutamate 5 / metabolism
  • Ribosomal Protein S6 Kinases / metabolism
  • Seizures / chemically induced
  • Seizures / metabolism
  • Seizures / pathology
  • Signal Transduction / drug effects
  • TOR Serine-Threonine Kinases / antagonists & inhibitors
  • TOR Serine-Threonine Kinases / metabolism*

Substances

  • 2-chloro-5-hydroxyphenylglycine
  • Carrier Proteins
  • Homer Scaffolding Proteins
  • Phenylacetates
  • Receptor, Metabotropic Glutamate 5
  • Picrotoxin
  • Ribosomal Protein S6 Kinases
  • TOR Serine-Threonine Kinases
  • Glycine
  • Pentylenetetrazole